Does the renal expression of Toll-like receptors play a role in patients with IgA nephropathy?
Language English Country Italy Media print-electronic
Document type Journal Article
Grant support
023728
Ministry of Health of the Czech Republic
LH15168
Ministry of Health of the Czech Republic
LM2015073
Research Infrastructure NanoEnviCz supported by the Ministry of Education, Youth and Sports of the Czech Republic
R01 DK082753
NIDDK NIH HHS - United States
R56 DK078244
NIDDK NIH HHS - United States
DK078244
National Institutes of Health, Czech Republic
DRO VFN 64165
Ministry of Health of the Czech Republic
PROGRES Q25/LF1
Ministry of Health of the Czech Republic
R01 DK078244
NIDDK NIH HHS - United States
DK082753
National Institutes of Health, Czech Republic
PubMed
31489594
PubMed Central
PMC7170228
DOI
10.1007/s40620-019-00640-z
PII: 10.1007/s40620-019-00640-z
Knihovny.cz E-resources
- Keywords
- ANCA-associated vasculitis, IgA nephropathy, Renal biopsy, Renal insufficiency, Toll-like receptors,
- MeSH
- Glomerular Filtration Rate MeSH
- Glomerulonephritis, IGA complications metabolism pathology MeSH
- Humans MeSH
- Case-Control Studies MeSH
- Severity of Illness Index MeSH
- Toll-Like Receptors metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Toll-Like Receptors MeSH
The onset of IgA nephropathy (IgAN), characterized by glomerular deposition of IgA-containing immune complexes, is often associated with synpharyngitic hematuria. Innate immune responses mediated by Toll-like receptors (TLR) may play a role in IgAN onset and/or progression. Here, we assessed the expression of TLR 4, 7, 8, and 9 in renal-biopsy specimens from patients with IgAN, with different degree of proteinuria and eGFR, compared with normal-kidney and disease-control tissues (ANCA-associated vasculitis). Renal-biopsy specimens from 34 patients with IgAN and 7 patients with ANCA-associated vasculitis were used. In addition, we used 15 healthy portions of renal-tissue specimens from kidneys after nephrectomy for cancer as control specimens. Expression of TLR 4, 7, 8, and 9 was assessed using immunohistochemical staining of paraffin-embedded renal-biopsy tissue specimens with specific antibodies and evaluated semiquantitatively by light microscopy. Linear discriminant analysis (LDA) was used to test whether intrarenal staining of TLR 4, 7, 8, and 9 distinguished patients with IgAN from controls or correlated with eGFR and/or proteinuria. eGFR was calculated using the creatinine-based formula. Moreover, the biopsies from patients with IgAN were scored according to the Oxford Classification. LDA showed that staining for TLR 4, 7, 8, and 9 was more intense in specimens from IgAN patients compared to normal kidney tissues. The intensity of intrarenal staining of TLRs discriminated four groups of IgAN patients with different eGFR and proteinuria and MEST scoring.
Department of Microbiology University of Alabama at Birmingham Birmingham AL 35294 2170 USA
Department of Pathology Institute of Clinical and Experimental Medicine 140 21 Prague Czech Republic
Fondazione Ricerca Molinette Regina Margherita Hospital 10134 Turin Italy
Institute of Rheumatology 1st Faculty of Medicine Charles University 128 50 Prague Czech Republic
See more in PubMed
Wyatt RJ, Julian BA (2013) IgA nephropathy. N Engl J Med. 20,368:2402–2414. doi: 10.1056/NEJMra1206793. PubMed DOI
Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, Eitner F et al. (2012) Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet. 8:e1002765. doi: 10.1371/journal.pgen.1002765. PubMed DOI PMC
Berthoux F, Suzuki H, Thibaudin L, Yanagawa H, Maillard N, Mariat C et al. (2012) Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy. J Am Soc Nephrol. 23(9):1579–1587. doi: 10.1681/ASN.2012010053. PubMed DOI PMC
Hastings MC, Moldoveanu Z, Suzuki H, Berthoux F, Julian BA, Sanders JT et al. (2013) Biomarkers in IgA nephropathy: relationship to pathogenetic hits. Expert Opin Med Diagn. 7(6):615–627. doi: 10.1517/17530059.2013.856878. PubMed DOI PMC
Caliskan Y, Kiryluk K (2014) Novel biomarkers in glomerular disease. Adv Chronic Kidney Dis. 21(2):205–216. doi: 10.1053/j.ackd.2013.12.002. PubMed DOI PMC
Himanshu K, Kiyoshi T, Shizuo A (2013) Toll-Like Receptors In: The Encyclopedia of biological chemistry. (Waltham, MA, USA:Elsevier; ), 396–401.
González-Guerrero C, Cannata-Ortiz P, Guerri C, Egido J, Ortiz A, Ramos AM (2017) TLR4-mediated inflammation is a key pathogenic event leading to kidney damage and fibrosis in cyclosporine nephrotoxicity. Arch Toxicol. 91(4):1925–1939. doi: 10.1007/s00204-016-1830-8. PubMed DOI
Muto M, Manfroi B, Suzuki H, Joh K, Nagai M, Wakai S et al. (2017) Toll-like receptor 9 stimulation induces aberrant expression of a proliferation-inducing ligand by tonsillar germinal center B cells in IgA nephropathy. J Am Soc Nephrol. 28(4):1227–1238. doi: 10.1681/ASN.2016050496. PubMed DOI PMC
Liu Y, Liu H, Peng Y, Liu F et al. (2014) New insights into the pathogenesis of IgA nephropathy: do Toll like receptor 9-B cell activation factor-IgA class switching recombination signaling axis induce IgA hyper-production? Ren Fail. 36(6):970–973. doi: 10.3109/0886022X.2014.916578. PubMed DOI
Li W, Peng X, Liu Y, Liu H, Liu F, He L et al. (2014) TLR9 and BAFF: their expression in patients with IgA nephropathy. Mol Med Rep. 10(3):1469–1474. doi: 10.3892/mmr.2014.2359. PubMed DOI
Coppo R, Camilla R, Amore A, Peruzzi L, Daprà V, Loiacono E et al. (2010) Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy. Clin Exp Immunol. 159(1):73–81. doi: 10.1111/j.1365-2249.2009.04045.x PubMed DOI PMC
Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J et al. (2009) Working group of the international IgA nephropathy network and the renal pathology society, The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 76(5):546–556. doi: 10.1038/ki.2009.168. PubMed DOI
Vandeginste BGM (1998) Handbook of Chemometrics and Qualimetrics, part B Waltham, MA, USA, Elsevier; Science
Program XLSTAT (www.xlstat.com).
Saito A, Komatsuda A, Kaga H, Togashi M, Okuyama S, Wakui H et al. (2016) Different expression patterns of Toll-like receptor mRNAs in blood mononuclear cells of IgA nephropathy and IgA vasculitis with nephritis. Tohoku J Exp Med. 240(3):199–208. doi: 10.1620/tjem.240.199. PubMed DOI
Nakata J, Suzuki Y, Suzuki H, Sato D, Kano T, Yanagawa H et al. (2014) Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy. PLoS One. 21;9(2): e89707. doi: 10.1371/journal.pone.0089707. PubMed DOI PMC
Donadio ME, Loiacono E, Peruzzi L, Amore A, Camilla R, Chiale F et al. (2014) Toll-like receptors, immunoproteasome and regulatory T cells in children with Henoch-Schönlein purpura and primary IgA nephropathy. Pediatr Nephrol. 29(9):1545–1551. doi: 10.1007/s00467-014-2807-6. PubMed DOI
Zou JN, Xiao J, Hu SS, Fu CS, Zhang XL, Zhang ZX et al. (2017) Toll-like receptor 4 signaling pathway in the protective effect of pioglitazone on experimental immunoglobulin A nephropathy. Chin Med J. 130(8):906–913. doi: 10.4103/0366-6999.204101. PubMed DOI PMC
Vergano L, Loiacono E, Albera R, Coppo R, Camilla R, Peruzzi L et al. (2015) Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy? J Nephrol. 28(1):51–58. doi: 10.1007/s40620-014-0086-8. PubMed DOI
Anders HJ, Andersen K, Stecher B (2013) The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int. 83(6):1010–1006. doi: 10.1038/ki.2012.440. PubMed DOI
Suzuki H, Suzuki Y, Narita I, Aizawa M, Kihara M, Yamanaka T et al. (2008) Toll-like receptor 9 affects severity of IgA nephropathy. J Am Soc Nephrol. 19(12):2384–2395. doi: 10.1681/ASN.2007121311. PubMed DOI PMC
Sallustio F, Cox SN, Serino G, Curci C, Pesce F, De Palma G et al. (2015) Genome-wide scan identifies a copy number variable region at 3p21.1 that influences the TLR9 expression levels in IgA nephropathy patients. Eur J Hum Genet. 23(7):940–948. doi: 10.1038/ejhg.2014.208. PubMed DOI PMC
Imaizumi T, Aizawa T, Segawa C, Shimada M, Tsuruga K, Kawaguchi S et al. (2015) Toll-like receptor 3 signaling contributes to the expression of a neutrophil chemoattractant, CXCL1 in human mesangial cells. Clin Exp Nephrol. 19(5):761–770. doi: 10.1007/s10157-014-1060-4. PubMed DOI
Zhu FG, Jiang W, Bhagat L, Wang D, Yu D, Tang JX et al. (2013) A novel antagonist of Toll-like receptors 7, 8 and 9 suppresses lupus disease-associated parameters in NZBW/F1 mice. Autoimmunity 46(7):419–428. doi: 10.3109/08916934.2013.798651. PubMed DOI
Kimura J, Ichii O, Miyazono K, Nakamura T, Horino T, Otsuka-Kanazawa S et al. (2014) Overexpression of Toll-like receptor 8 correlates with the progression of podocyte injury in murine autoimmune glomerulonephritis. Sci Rep. 4:7290. doi: 10.1038/srep07290. PubMed DOI PMC